Excellant Post on Sunday, 06/11/17 07:19:22 PM
#34 on the break out boards. There are a lot of people watching ENDV with laser like precision. This stock can move at a moments notice with no news.
This reminds me of OWC- when I was in it for three months and was locked in a tight trading range. And then it just exploded to the upside. ENDV which has platform for both Biologics and Bio Electronic Medicine and has a lot more potential than the medical marijuana sector which are mostly pumps there are a few legit companies the rest of them I wouldn't touch.
On the other hand Tesla, Apple, Google, Johnson & Johnson, Medtronic, GE, GSK, PLSE (Robert Duggan) founder of PCYC are investing heavy in Biologics and Bio Electronic Medicine.
Biologics and Bio electronic Medicine is going to be a big piece of the pie in Big Pharma and Biotech.
Once in a while a micro cap grows into a mid cap or a blue chip. PCYC was once a penny stock and sold for 21 Billion interestingly Robert Duggan the founder of PCYC is the largest investor in Pulse Bio Sciences. ENDV is actually ahead of PLSE in R&D and has the more impressive patent portfolio.
The great potential lies in the two distinct platforms ENDV has one in Bio electronic Medicine and one in Biologics.
ENDV and Why Square Waves? ( Bio Electronic Medicine)
Sine waves take too long to reach their peak intensity. The lower slew rate means that they are not effective in producing a cellular/tissue response.
Triangle and sawtooth waves also suffer from a lower slew rate, meaning that they are not effective in producing a cellular/tissue response.
Endonovo’s TVEMF device produces a patented square waveform, which was proven the most effective waveform to increase cell growth and the production of over 200 growth factors and cytokines.
Cytotronics™ Platform (Biologocs)
Our Cytotronics™ platform uses Time-Varying Electromagnetic Field (TVEMF) technology to expand and enhance the therapeutic properties of stem cells, immune cells and for use in tissue engineering. The goal of our Cytotronics™ platform is to create optimized cell-based therapies with greater therapeutic potential than the un-modulated cells currently being used in regenerative medicine.
The origins of our Cytotronics™ platform dates back to experiments conducted at NASA to expand stem cells ex vivo and to create therapies that could be used to treat astronauts during long term space exploration. The results of those experiments revealed that Time-Varying Electromagnetic Fields (TVEMF) could be used to expand stem cells in the lab and resulted in the increased expression of dozens of genes related to cell growth, tumor suppression, cell adhesion and extracellular matrix production
ENDV 15 Million Market Cap
PLSE 470 Million Market cap
MEOBF 1 Billion Market cap
In the coming weeks and months ENDV market cap will move more in line with its competitors possibly surpassing some of them. I honestly believe this a billion dollar company in the making.
$ENDV
#34 on the break out boards. There are a lot of people watching ENDV with laser like precision. This stock can move at a moments notice with no news.
This reminds me of OWC- when I was in it for three months and was locked in a tight trading range. And then it just exploded to the upside. ENDV which has platform for both Biologics and Bio Electronic Medicine and has a lot more potential than the medical marijuana sector which are mostly pumps there are a few legit companies the rest of them I wouldn't touch.
On the other hand Tesla, Apple, Google, Johnson & Johnson, Medtronic, GE, GSK, PLSE (Robert Duggan) founder of PCYC are investing heavy in Biologics and Bio Electronic Medicine.
Biologics and Bio electronic Medicine is going to be a big piece of the pie in Big Pharma and Biotech.
Once in a while a micro cap grows into a mid cap or a blue chip. PCYC was once a penny stock and sold for 21 Billion interestingly Robert Duggan the founder of PCYC is the largest investor in Pulse Bio Sciences. ENDV is actually ahead of PLSE in R&D and has the more impressive patent portfolio.
The great potential lies in the two distinct platforms ENDV has one in Bio electronic Medicine and one in Biologics.
ENDV and Why Square Waves? ( Bio Electronic Medicine)
Sine waves take too long to reach their peak intensity. The lower slew rate means that they are not effective in producing a cellular/tissue response.
Triangle and sawtooth waves also suffer from a lower slew rate, meaning that they are not effective in producing a cellular/tissue response.
Endonovo’s TVEMF device produces a patented square waveform, which was proven the most effective waveform to increase cell growth and the production of over 200 growth factors and cytokines.
Cytotronics™ Platform (Biologocs)
Our Cytotronics™ platform uses Time-Varying Electromagnetic Field (TVEMF) technology to expand and enhance the therapeutic properties of stem cells, immune cells and for use in tissue engineering. The goal of our Cytotronics™ platform is to create optimized cell-based therapies with greater therapeutic potential than the un-modulated cells currently being used in regenerative medicine.
The origins of our Cytotronics™ platform dates back to experiments conducted at NASA to expand stem cells ex vivo and to create therapies that could be used to treat astronauts during long term space exploration. The results of those experiments revealed that Time-Varying Electromagnetic Fields (TVEMF) could be used to expand stem cells in the lab and resulted in the increased expression of dozens of genes related to cell growth, tumor suppression, cell adhesion and extracellular matrix production
ENDV 15 Million Market Cap
PLSE 470 Million Market cap
MEOBF 1 Billion Market cap
In the coming weeks and months ENDV market cap will move more in line with its competitors possibly surpassing some of them. I honestly believe this a billion dollar company in the making.
$ENDV
